FEMY FEMY
Company Profile ↓Company Overview
FEMY (FEMY) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 17.2% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $2.29M (+40.8% YoY); net profit $-18.63M.
- Trailing 12 Months Year-on-year growth — revenue +40.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 17.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 17.18% |
| 1 Year: | 40.77% |
Stock Price Performance
| 1 Year: | -81.37% |
| 6 Months: | -71.22% |
| 3 Months: | -62.38% |
| 1 Month: | -22.22% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)39.45 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 17.2% over 5 years.
CONS
- Trading 85.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 183.23K | 313.21K | 329.77K | 326.01K | 269.58K | 321.40K | 303.11K | 347.46K | 293.98K | 320.51K | 244.36K | 271.14K | 221.48K | 554.91K | 341.26K | 409.27K | 729.39K | 424.89K |
| Gross Profit | 127.96K | 222.77K | 236.73K | 218.38K | 164.18K | 198.73K | 200.76K | 216.00K | 188.86K | 210.04K | 158.18K | - | - | - | - | - | - | - |
| Operating Income | -1.48M | -1.56M | -1.83M | -1.90M | -2.25M | -2.88M | -2.66M | -3.06M | -3.04M | -2.94M | -4.08M | -3.46M | -4.48M | -5.12M | -5.46M | -3.85M | -3.65M | -4.22M |
| Net Income | -1.49M | -1.57M | -1.83M | -1.08M | -2.26M | -2.88M | -2.63M | -2.98M | -2.95M | -2.89M | -4.00M | -3.60M | -4.68M | -5.41M | -5.90M | -4.59M | -4.19M | 846.10K |
| Diluted EPS | -1.55 | -1.64 | -1.84 | -0.52 | -0.19 | -0.24 | -0.22 | -0.25 | -0.25 | -0.22 | -0.26 | -0.17 | -0.21 | -0.24 | -0.23 | -0.16 | -0.10 | 0.00 |
| R&D Expense | 888.70K | 995.62K | 995.02K | 894.87K | 1.14M | 1.42M | 1.47M | 1.65M | 1.54M | 1.53M | 2.07M | 1.77M | 1.98M | 2.30M | 2.97M | 1.41M | 1.38M | 1.31M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.04M | 1.18M | 1.21M | 1.07M | 1.63M | 2.29M |
| Gross Profit | 731.38K | 809.30K | 764.28K | - | - | - |
| Operating Income | -6.93M | -8.34M | -11.60M | -14.51M | -17.79M | -17.59M |
| Net Income | -6.91M | -7.54M | -11.39M | -14.25M | -18.82M | -18.63M |
| Diluted EPS | -7.20 | -1.12 | -0.96 | -0.93 | -0.85 | -0.47 |
| R&D Expense | 4.13M | 4.08M | 5.81M | 7.21M | 8.22M | 7.58M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 7.61M | 28.58M | 16.90M | 27.76M | 12.45M | 20.72M |
| Total Equity | -45.37M | -51.82M | 26.33M | 15.24M | 18.35M | 2.30M | 5.87M |
| Cash & Equivalents | - | 3.32M | 24.78M | 12.96M | 21.72M | 3.45M | 9.27M |
| Total Liabilities | - | 4.08M | 2.24M | 1.65M | 9.40M | 10.14M | 14.85M |
| Current Liabilities | - | 2.89M | 1.69M | 1.53M | 3.05M | 8.58M | 3.64M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.93M | -7.93M | -10.73M | -11.28M | -19.44M | -18.69M |
| Investing Cash Flow | 968.32K | -306.87K | -407.48K | -143.92K | -847.76K | -630.10K |
| Financing Cash Flow | 871.65K | 29.70M | -681.64K | 20.18M | 2.03M | 25.14M |
| Capital Expenditure | -8.35K | -306.87K | -407.48K | -143.92K | -761.71K | -525.01K |
| Free Cash Flow | -4.94M | -8.24M | -11.14M | -11.42M | -20.21M | -19.22M |
| Share Buybacks | - | - | 0 | 229.95K | 60.75K | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | 70.5% | 68.6% | 63.4% | - | - | - |
| Operating Margin % | -668.0% | -706.7% | -961.7% | -1,353.4% | -1,091.8% | -767.0% |
| Net Margin % | -666.2% | -639.0% | -944.6% | -1,329.1% | -1,155.0% | -812.3% |
| ROE % | 13.3% | -28.6% | -74.8% | -77.6% | -816.5% | -317.4% |
| ROCE % | -147.0% | -31.0% | -75.5% | -58.7% | -460.5% | -102.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FEMY
FEMY Stock Price, Quote & Chart - ChartMill
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5EQ0wyX1hwVnlxQ19kbFdhZV9XWGh3NnE3M2JoUlBFTEhQTzFBN2JSZ202OEw0NnV5WVQyWTNMVHE3LUliWWR2Vy1nWkJKejNFVmt2RzVsc0R0RDVsOEhv?oc=5" target="_blank">FEMY Stock Price, Quote & Chart</a>&nbs…
Price to book forward of Femasys Inc. – NASDAQ:FEMY - TradingView
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNbThMZ0NOV2tkZWF0dTY4SkVCaWt4dmJQaUVmdkdUZW5FeTQ5NTBWWklVVkJXS0hhekNRMVdDQ1ZlSU1ycUtJclgybnByUmtEWEhoS3cwdWU3NS1rUTNaSXgwVjlveUZXaHVXaC1DNjVlYWxzWTlHcEc0RWVWRklVTkVaS0JKc083S1VXY2…
Femasys (FEMY) investors back directors and KPMG auditor at 2026 meeting - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOOFBzLWlXdmROWVRrd2ZfeUJEeC0tNjZqNHdUd2ZTZ1lzTTVMd0V2VldUODJ0REhOX3JlcWtJaW50aXRrOHhHMXJ0ZGJsejR5b0U4MzZkQUw4Wm9Ja25ZS0daeVBZVHA1Z1VWbFpGUnhISzMzanRjNXZOeXlkcWl2NVEtZXl4bHd3Z0NuZz…
Femasys Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPYVlaZ2JIYkdjRG9TYWZUYUV3dzBVU3F2UlM4dWd1ekVCQjNfbGRnemtCVmo1bzBRbVFHOU1xdmZ5LVIzcDJPT19DR1JHSV90R3V3M2luYjhUaDRlbk1nZHFDdUZOYVg2WlREb3VaYnZEVUZobDYtVThxQWF6WGxscUE4RGVXYUJ0SWI1SX…
FEMY Technical Analysis & Stock Price Forecast - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE51SjFrdy1DUTZib0NGaUtLWnVMUkZuZy1VRGlVbzYwWURtN1p2MVY1ak4yQ2tKSUNST1ZnNkRidGx4LXN4bjR6VnpQM3JvcXBwUlQ2VlAtb0poUQ?oc=5" target="_blank">FEMY Technical Analysis & Stock Price Forecas…
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxNeVc4bEt0czdXaVJPYUNpX2ozdU1ueGN0YlZvZlZFeEt1WWh5djQ3S3lmUjRsTG9LQkRYMEhma2dqUGJQanBoVHdBRUJZZmZGdzhySlVuNzdjdFNyTXhrU0FnRDdEeXdkR2JRVG10Q2xMNGNGSnlURGhlcWVXdWlkS1lEdnhJdU16OU5MUF…
FEMY — Frequently Asked Questions
What is the current share price of FEMY?
As of 2026-08-05 17:25 PDT, FEMY trades at $3.01 on NASDAQ/NYSE. Its 52-week range is $2.78 to $20.80.
What is the P/E ratio of FEMY?
FEMY trades at a trailing price-to-earnings (P/E) ratio of -6.40.
Is FEMY a good stock to buy?
This page provides a data-driven analysis of FEMY, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.